HHHuichi Hou

Huichi Hou

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Research Subjects


Huichi Hou has a total of 3 co-authors. Here are the top co-authors by number of shared publications:

  • Jie An

    Department of Pathology, The Bethune International Peace Hospital, Shijiazhuang, 050082, China

    1 shared publication
  • Kang Li

    Department of General Surgery, The Bethune International Peace Hospital, 398 Zhongshan West Road, Shijiazhuang, 050082, China

    1 shared publication
  • Wei Liu

    Department of General Surgery, The Bethune International Peace Hospital, 398 Zhongshan West Road, Shijiazhuang, 050082, China

    1 shared publication

Latest Publications

  • Retracted

    MiR-429 regulates gastric cancer cell invasiveness through ZEB proteins

    by Wei Liu, Jie An, Kang Li, Huichi Hou

    MicroRNAs (miRNAs) play an essential role in the tumorigenesis of gastric carcinoma (GC). MiR-429 has been recently reported to inhibit GC growth; however, whether miR-429 may also regulate the invasion of GC cells is unknown. Here, we showed that miR-429 levels were significantly decreased and ZEB1 and ZEB2 levels were significantly increased in GC specimens, compared to the paired adjacent non-tumor gastric tissue. Moreover, the levels of miR-429 and ZEB1 or ZEB2 inversely correlated in GC specimens. Bioinformatics analyses showed that miR-429 targeted the 3'-untranslated region of both ZEB1 and ZEB2 mRNA to inhibit their translation, which was confirmed by luciferase reporter assay. Overexpression of miR-429 inhibited ZEB1/2-mediated cell invasiveness, while depletion of miR-429 augmented it. Together, our data suggest that miR-429 suppression in GC promotes ZEB1/2-mediated cancer cell invasion.